| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |